AXT to distribute OpenSpecimen biobanking software solution
AXT and Krishagni Solutions have announced a distributorship agreement for the OpenSpecimen biobanking software solution for clinical researchers. The product is designed to speed up workflow, allowing users to spend less time tracking specimens.
Based on an open-source platform designed by Krishagni Solutions, OpenSpecimen (formerly known as caTissue Plus) is currently used by research institutions across 12 countries where it manages biospecimens from collection to utilisation. By providing a central place to manage samples and their associated data, it is said to take the hassle out of operations such as collection, managing consent status, quality control, specimen request and distribution.
“While the generation of data is the process that usually gets the spotlight, the ability to manage biological and libraries is crucial to any clinical research operation,” said AXT National Life Science Product Manager Desley Pitcher. “OpenSpecimen will allow researchers to more efficiently concentrate their efforts on their research with the knowledge that their specimens and data are being managed using a robust yet user-friendly solution providing the highest level of confidence in their findings.”
The system has been designed with flexibility and customisation in mind, enabling users with only limited IT experience to perform functions like adding custom fields or forms to tailor OpenSpecimen to their specific requirements. In the event that more detailed customisation is required, the team at Krishagni Solutions offers a professional support service.
“We have been involved with OpenSpecimen and caTissue Plus (that was originally developed by the National Cancer Institute and the US Government) since 2004, so have an intimate understanding of its workings and capabilities,” said Srikanth Adiga from Krishagni Solutions. “We work with users of the software and provide training, remote system administration, regular user group meetings and system support. For new adopters, we can work with you to customise and configure the system as well as providing services like data migration and system integration.”
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...
Global competition targets 'undruggable' cancer protein
A new global competition offering over US$500,000 in prizes aims to spur drug discovery...
SMi Systems appoints Dr Ankur Mutreja as Senior Advisor
Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...